IHS Chemical Week

Regions :: North America :: U.S.

Moberg Pharma acquires three OTC brands in the US from Bayer HealthCare

5:57 AM MST | December 6, 2013 | Natasha Alperowicz

Moberg Pharma (Stockholm) announced today that it has signed a deal to acquire three well-established OTC brands in the United States from Bayer HealthCare for 32 million Swedish kronor ($4.8 million) in cash. Total annual sales for the brands are approximately SK20 million. The transaction is expected to close before the end of 2013.    The acquired portfolio includes Domeboro, a topical astringent used for relieving itch and minor skin irritations; Vanquish, an internal analgesic; and Fergon, an iron supplement. The brands will be sold through...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa